Chargement en cours...
Impact of Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045% in the Management of Plaque Psoriasis in Adults
Halobetasol propionate and tazarotene lotion 0.01%/0.045% (HP/TAZ) is a topical medication approved for the treatment of plaque psoriasis in adults. As a treatment modality, HP/TAZ has a combinatory therapeutic effect because it contains both a corticosteroid (HP) and a retinoid (TAZ) component. Her...
Enregistré dans:
| Publié dans: | Clin Cosmet Investig Dermatol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7295208/ https://ncbi.nlm.nih.gov/pubmed/32606876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CCID.S252426 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|